Search For "sirol"
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
Updated : 2 years, 9 months ago IST
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
Read More
Excellent 12-month results from SELUTION SFA trial presented at JET
Updated : 3 years ago IST
Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloo
Read More
Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated
Updated : 3 years ago IST
Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval
Read More
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SEL
Updated : 3 years, 1 month ago IST
Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the Cardiac & Vascular Institute in Florida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial
Read More
Concept Medical received IDE approval to investigate safety and efficacy o
Updated : 3 years, 1 month ago IST
Tampa (Florida) [US], May 1 (ANI/PRNewswire): The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary arteries.
Read More
Over 1,000 patients enrolled in Landmark SELUTION DeNovo Study
Updated : 3 years, 2 months ago IST
Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment st
Read More
Concept Medical granted Investigational Device Exemption (IDE) approval fo
Updated : 3 years, 3 months ago IST
Tampa (Florida) [US], February 13 (ANI/PRNewswire): Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon.
Read More
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SE
Updated : 3 years, 4 months ago IST
Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
Read More
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE
Updated : 3 years, 4 months ago IST
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
Read More
Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2
Updated : 3 years, 6 months ago IST
Tampa (Florida) [US], December 3 (ANI/PRNewswire): VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled 'Sirolimus Coated Balloon in PAD Treatment: Choice o
Read More
SIRONA completes enrollment - A leap in the DCB treatment of femoropoplite
Updated : 3 years, 7 months ago IST
Tampa (Florida) [US], October 21 (ANI/PRNewswire): Concept Medical Inc. announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA - Concept Medical Inc.) V/S Paclitaxel DCB
Read More
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients
Updated : 3 years, 8 months ago IST
Tampa (Florida) [US], September 28 (ANI/PRNewswire): ABILITY DIABETES-GLOBAL (ADG), is the World's largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing head-to-head the Sirolimus eluting stent, Abluminus DES+ (Concept Medical Inc.) with the XIENCE fam
Read More